Nicotinamide treatment reduced reactive gliosis in diabetic retinas at 4 and 12 weeks after induction of diabetes (both p < 0.001) in accordance with Guzyk’s study showing that nicotinamide treatment decreased retinal GFAP expression in the retina at 8 weeks after diabetes onset [25]. This evidence concerns the gene GFAP and diabetes mellitus.